is retatrutide illegal Weight Loss Results:Trial Data and FDA Status What is Retatrutide? Is it

President Trump recently announced a deal with drugmakers to expand access to GLP-1 drugs to Medicare patients starting in 2026

The world of weight loss medications has grown rapidly in recent years, especially with the introduction of GLP-1 receptor agonists

Standard qualification criteria include: BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related health condition (high blood pressure, type 2 diabetes, high cholesterol) No history of certain medical conditions (medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2) Not pregnant or breastfeeding Top 8 GLP-1 Telehealth Providers Compared 1

A plateau, typically defined as little or no weight change for eight to 12 weeks, is not a sign of failure but rather the body adapting to a lower weight